Maria Godinho Pires João, Cristina2017-06-212017-06-212014-091646-0758PURE: 411526PURE UUID: b6f06ddf-af2d-40ae-86b3-57c55e229fb2researchoutputwizard: 45938PubMed: 25409226WOS: 000344417100023Scopus: 84908397086http://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5411/4081The Portuguese group of multiple myeloma of the Portuguese Society of Hematology proposes a national protocol for diagnosis and clinical follow-up of monoclonal gammopathies. The proposed protocol aims to standardize clinical management of monoclonal gammopathies. Furthermore, it would also define the major risk factors for progression to Multiple Myeloma that require a precocious close articulation between general practitioners and a Hematology Clinic.4396915porPROGRESSIONDisease ProgressionBIOLOGICAL INSIGHTSUNDETERMINED SIGNIFICANCE MGUSRISKEARLY TREATMENT STRATEGIESMonoclonal Gammopathy of Undetermined SignificancePrognosisPREVALENCEMANAGEMENTSMOLDERING MULTIPLE-MYELOMACLASSIFICATIONMALIGNANT-TRANSFORMATIONLong-Term CarePortugaljournal articlehttp://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5411/4081